Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Post-translational regulation of the ERK phosphatase DUSP6/MKP3 by the mTOR pathway

Abstract

MAP kinases phosphatases (MKPs) belong to the dual-specificity phosphatase family (DUSP) and dephosphorylate phosphothreonine and phosphotyrosine within MAP kinases. We had previously shown that DUSP6/MKP-3 was phosphorylated and degraded upon growth factor stimulation, in a MEK-dependent manner. Here we show that another pathway involved in growth factor signaling, the PI3K/mTOR signaling pathway, accounts for a part of the phosphorylation and degradation of DUSP6 induced by serum growth factors, as evidenced by experiments using pharmacological inhibitors of PI3 kinase and mammalian target of rapamycin (mTOR). Moreover, specific agonists of the mTOR pathway, such as amino acids or insulin/IGF-1, which do not activate extracellular signal regulated kinases (ERKs) in our cellular model, were also able to induce the phosphorylation and degradation of DUSP6. However, a basal activity of MEK was required for the mTOR pathway-mediated phosphorylation to occur. Mutagenesis studies identified serine 159 within DUSP6 as the target of the mTOR pathway. The ERK phosphatase DUSP6 may thus constitute a novel branch-point of the crosstalk between two major signaling pathways induced by growth factors, the MEK/ERK pathway and the PI3K/mTOR pathway.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5

Similar content being viewed by others

References

  • Averous J, Proud CG . (2006). When translation meets transformation: the mTOR story. Oncogene 25: 6423–6435.

    Article  CAS  Google Scholar 

  • Avruch J, Hara K, Lin Y, Liu M, Long X, Ortiz-Vega S et al. (2006). Insulin and amino-acid regulation of mTOR signaling and kinase activity through the Rheb GTPase. Oncogene 25: 6361–6372.

    Article  CAS  Google Scholar 

  • Camps M, Nichols A, Gillieron C, Antonsson B, Muda M, Chabert C et al. (1998). Catalytic activation of the phosphatase MKP-3 by ERK2 mitogen-activated protein kinase. Science 280: 1262–1265.

    Article  CAS  Google Scholar 

  • Chambard JC, Lefloch R, Pouysségur J, Lenormand P . (2007). ERK implication in cell cycle regulation. Biochim Biophys Acta 1773: 1299–1310.

    Article  CAS  Google Scholar 

  • Echevarria D, Martinez S, Marques S, Lucas-Teixeira V, Belo JA . (2005). Mkp3 is a negative feedback modulator of Fgf8 signaling in the mammalian isthmic organizer. Dev Biol 277: 114–128.

    Article  CAS  Google Scholar 

  • Harrington LS, Findlay GM, Gray A, Tolkacheva T, Wigfield S, Rebholz H et al. (2004). The TSC1-2 tumor suppressor controls insulin-PI3K signaling via regulation of IRS proteins. J Cell Biol 166: 213–223.

    Article  CAS  Google Scholar 

  • Jeffrey KL, Camps M, Rommel C, Mackay CR . (2007). Targeting dual-specificity phosphatases: manipulating MAP kinase signalling and immune responses. Nat Rev Drug Discov 6: 391–403.

    Article  CAS  Google Scholar 

  • Kawakami Y, Rodriguez-Leon J, Koth CM, Buscher D, Itoh T, Raya A et al. (2003). MKP3 mediates the cellular response to FGF8 signalling in the vertebrate limb. Nat Cell Biol 5: 513–519.

    Article  CAS  Google Scholar 

  • Kim M, Cha GH, Kim S, Lee JH, Park J, Koh H et al. (2004). MKP-3 has essential roles as a negative regulator of the Ras/mitogen-activated protein kinase pathway during Drosophila development. Mol Cell Biol 24: 573–583.

    Article  CAS  Google Scholar 

  • Land SC, Tee AR . (2007). Hypoxia-inducible factor 1alpha is regulated by the mammalian target of rapamycin (mTOR) via an mTOR signaling motif. J Biol Chem 282: 20534–20543.

    Article  CAS  Google Scholar 

  • Lenormand P, McMahon M, Pouysségur J . (1996). Oncogenic Raf-1 activates p70 S6 kinase via a mitogen-activated protein kinase-independent pathway. J Biol Chem 271: 15762–15768.

    Article  CAS  Google Scholar 

  • Li C, Scott DA, Hatch E, Tian X, Mansour SL . (2007). Dusp6 (Mkp3) is a negative feedback regulator of FGF-stimulated ERK signaling during mouse development. Development 134: 167–176.

    Article  CAS  Google Scholar 

  • Ma L, Chen Z, Erdjument-Bromage H, Tempst P, Pandolfi PP . (2005). Phosphorylation and functional inactivation of TSC2 by Erk implications for tuberous sclerosis and cancer pathogenesis. Cell 121: 179–193.

    Article  CAS  Google Scholar 

  • Mamane Y, Petroulakis E, LeBacquer O, Sonenberg N . (2006). mTOR, translation initiation and cancer. Oncogene 25: 6416–6422.

    Article  CAS  Google Scholar 

  • Marchetti S, Gimond C, Chambard JC, Touboul T, Roux D, Pouysségur J et al. (2005). Extracellular signal-regulated kinases phosphorylate mitogen-activated protein kinase phosphatase 3/DUSP6 at serines 159 and 197, two sites critical for its proteasomal degradation. Mol Cell Biol 25: 854–864.

    Article  CAS  Google Scholar 

  • Marchetti S, Gimond C, Roux D, Gothié E, Pouysségur J, Pagès G . (2004). Inducible expression of a MAP kinase phosphatase-3-GFP chimera specifically blunts fibroblast growth and ras-dependent tumor formation in nude mice. J Cell Physiol 199: 441–450.

    Article  CAS  Google Scholar 

  • McKay MM, Morrison DK . (2007). Integrating signals from RTKs to ERK/MAPK. Oncogene 26: 3113–3121.

    Article  CAS  Google Scholar 

  • Murphy LO, Blenis J . (2006). MAPK signal specificity: the right place at the right time. Trends Biochem Sci 31: 268–275.

    Article  CAS  Google Scholar 

  • Owens DM, Keyse SM . (2007). Differential regulation of MAP kinase signalling by dual-specificity protein phosphatases. Oncogene 26: 3203–3213.

    Article  CAS  Google Scholar 

  • Pouysségur J, Lenormand P . (2003). Fidelity and spatio-temporal control in MAP kinase (ERKs) signalling. Eur J Biochem 270: 3291–3299.

    Article  Google Scholar 

  • Schalm SS, Blenis J . (2002). Identification of a conserved motif required for mTOR signaling. Curr Biol 12: 632–639.

    Article  CAS  Google Scholar 

  • Smith TG, Karlsson M, Lunn JS, Eblaghie MC, Keenan ID, Farrell ER et al. (2006). Negative feedback predominates over cross-regulation to control ERK MAPK activity in response to FGF signalling in embryos. FEBS Lett 580: 4242–4245.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This work was supported by a grant from the French Association for Research on Cancer (ARC) and by a fellowship from the American Institute for Cancer Research to OB and GP. GP was also sponsored by the Ligue Nationale contre le Cancer (‘Equipe labellisée’). We are grateful to Dr Jean-Claude Chambard and Philippe Lenormand for helpful discussions about the manuscript.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to C Gimond.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bermudez, O., Marchetti, S., Pagès, G. et al. Post-translational regulation of the ERK phosphatase DUSP6/MKP3 by the mTOR pathway. Oncogene 27, 3685–3691 (2008). https://doi.org/10.1038/sj.onc.1211040

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1211040

Keywords

This article is cited by

Search

Quick links